M. V. van Kats

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry

M. Pepels, V. Tjan-Heijnen, F. Erdkamp, 2023, The Lancet regional health. Europe.

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.

M. Pepels, V. Tjan-Heijnen, N. Peters, 2023, Clinical breast cancer.